| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-9,139 | -6,645 | -6,885 | -5,869 | -5,685 | ||
Adjustments to reconcile net loss to net cash (used in) provided by operating activities | ||||||
Depreciation and amortization | ||||||
1,396 | 1,366 | 1,190 | 1,145 | 1,047 | ||
Noncash operating lease cost | ||||||
315 | 309 | 1,102 | -643 | 214 | ||
Stock-based compensation expense | ||||||
1,249 | 1,201 | 1,402 | 1,646 | 609 | ||
Change in fair value of convertible preferred stock warrant liability | ||||||
- | 0 | 0 | 1,269 | 134 | ||
Accretion of noncash interest and debt reduction | ||||||
- | 0 | 53 | 81 | 22 | ||
Other | ||||||
64 | -354 | -75 | 15 | -13 | ||
Changes in operating assets and liabilities | ||||||
Accounts receivable | ||||||
2,208 | -1,144 | -2,934 | 4,355 | -1,346 | ||
Inventory and other deferred costs | ||||||
1,832 | 1 | 1,067 | 654 | -548 | ||
Prepaid expenses and other current assets | ||||||
-178 | -851 | 3,153 | 149 | 108 | ||
Accounts payable | ||||||
2,385 | 924 | 637 | 657 | -820 | ||
Accrued and other current liabilities | ||||||
729 | 923 | 1,643 | -2,154 | 1,587 | ||
Contract liabilities | ||||||
-1,569 | 2,250 | -8,140 | -2,449 | 1,419 | ||
Other long-term liabilities | ||||||
-83 | -271 | -275 | -270 | -260 | ||
Net cash (used in) provided by operating activities | ||||||
-8,643 | 2,405 | -9,638 | -10,902 | 66 | ||
Cash flows from investing activities: | ||||||
Purchases of available-for-sale debt securities | ||||||
27,242 | - | - | - | - | ||
Proceeds from maturities of available-for-sale debt securities | ||||||
27,283 | - | - | - | - | ||
Purchases of property and equipment | ||||||
76 | 1,913 | 3,668 | 1,841 | 960 | ||
Net cash used in investing activities | ||||||
-35 | -34,848 | -43,930 | -1,841 | -960 | ||
Cash flows from financing activities: | ||||||
Payments of costs related to initial public offering | ||||||
- | 247 | 1,959 | 1,514 | 477 | ||
Proceeds from borrowings | ||||||
- | 0 | 0 | 0 | 20,000 | ||
Payments of borrowing costs | ||||||
- | 0 | 0 | 0 | 490 | ||
Repayments under borrowing arrangements | ||||||
- | 0 | 20,000 | 0 | 5,000 | ||
Proceeds from exercise of stock options | ||||||
323 | 34 | 67 | 258 | 353 | ||
Net cash provided by financing activities | ||||||
323 | 471 | -22,686 | 142,777 | 14,386 | ||
Effect of exchange rates on cash flows and cash equivalents | ||||||
3 | - | - | - | 1 | ||
Net change in cash and cash equivalents | ||||||
-8,352 | - | - | - | 13,493 | ||